Search

Monthly updates with the latest reports on West Nile virus cases in Europe.

The scope of this document is to provide a thematic prioritisation and a framework to guide the choice of VMP studies to be conducted.

In this scoping review, covering publications from January 2000 to June 2025, probable or certain transmission cases of arbovirus through substances of human origin SoHO were identified for WNV, DENV and Zika virus.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1 - 7 August 2026, and includes updates on Ebola, chikungunya, dengue, West Nile Virus infection, Crimean-Congo haemorrhagic fever, Vibrio, respiratory virus epidemiology in the EU/EEA, World Pride, Middle East respiratory syndrome coronavirus, and expert deployments.

This EQA was organised within the IBDLabNet framework on behalf of ECDC to assess current EU/EEA laboratory capacity for the detection and characterisation of S. pneumoniae in both non-culture and culture-based settings.

This external quality assessment was organised within the IBDLabNet framework to assess current EU/EEA laboratory capacity for the diagnosis and characterisation of N. meningitidis in both non-culture and culture-based settings, and to identify areas requiring further harmonisation or technical support.

This external quality assessment (EQA) was organised within the IBDLabNet framework on behalf of the ECDC to assess current EU/EEA laboratory capacity for the detection and characterisation of H. influenzae in both non-culture and culture-based settings.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 - 31 July 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, dengue, avian influenza A(H9N2), expert deployment, cholera, chikungunya virus disease, Vibrio, World Pride, and an overview of respiratory virus epidemiology in the EU/EEA.

This report provides an overview of measles and rubella cases reported to ECDC through The European Surveillance System (TESSy).

In 2024, 73 tetanus cases were reported in the EU/EEA 15 of which (21%) were confirmed cases.

The 2025 Euro-GASP EQA scheme results confirm that participating laboratories continue to demonstrate a high level of competency in the recovery and susceptibility testing of N. gonorrhoeae. With 27 countries participating and universal adherence to EUCAST guidelines, the network shows strong methodological consistency.

Transmission of hepatitis B virus (HBV) from a mother to a child (also referred to as vertical transmission), is low in EU/EEA countries, with few cases attributed to this route among acute notifications.

This report provides an overview of progress toward the interim targets for elimination for 2025 included in the WHO’s European Regional Action Plan.

For 2024, 30 EU/EEA countries reported 37 605 cases of hepatitis B virus (HBV) infection, corresponding to a crude rate of 7.5 cases per 100 000 population.

In 2024, 28 540 cases of hepatitis C were reported in 29 EU/EEA countries, corresponding to a crude rate of 7.1 cases per 100 000 population.

This survey report describes the testing requirements for Hepatitis C virus in different EU/EEA countries.

This survey report aims to describe the testing requirements for hepatis B virus in different EU/EEA countries.

In 2024, 151 cases of diphtheria were reported to ECDC: 83 cases due to toxigenic Corynebacterium diphtheriae and 65 cases due to Corynebacterium ulcerans.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18 - 24 July 2026, and includes updates on Ebola, West Nile Virus infections, Crimean-Congo haemorrhagic fever, malaria, dengue, expert deployment, World Pride, and an overview of respiratory virus epidemiology in the EU/EEA.

Whether you join the festival in Amsterdam or celebrate at local pride gatherings, we encourage you to follow this public health advice to protect yourselves and others for the duration of this exciting event.

This document is the main module of a suite of documents that together comprise guidance for integrated respiratory virus surveillance in the EU/EEA.

This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11 - 17 July 2026, and includes updates on Ebola, respiratory virus epidemiology, swine influenza A(H3N2), Influenza A(H5), Vibrio, West Nile virus infections, Crimean-Congo haemorrhagic fever (CCHF), expert deployments, Influenza A(H5N1), cyclosporiasis, World Pride, and mpox.

Weekly update with the latest reports on West Nile virus cases in Europe.

This report presents data on mpox cases reported to the European Surveillance System (EpiPulse Cases). EU/EEA countries report case based data to ECDC on diagnosed mpox cases. For case numbers by countries, Western Balkans and Türkiye are included.

Since 2022, an increasing number of European countries have reported cases of gonorrhoea caused by ceftriaxone-resistant Neisseria gonorrhoeae, including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains.